Media coverage about Rennova Health (NASDAQ:RNVA) has trended somewhat positive recently, according to Accern. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Rennova Health earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 45.4282357193354 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Rennova Health (RNVA) traded down 3.4011% during trading on Thursday, hitting $0.2897. The stock had a trading volume of 467,089 shares. Rennova Health has a 12-month low of $0.28 and a 12-month high of $11.70. The firm’s market cap is $3.65 million. The stock’s 50 day moving average price is $0.37 and its 200 day moving average price is $0.79.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at

Rennova Health Company Profile

Rennova Health, Inc (Rennova), formerly CollabRx, Inc, is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers.

Insider Buying and Selling by Quarter for Rennova Health (NASDAQ:RNVA)

Receive News & Stock Ratings for Rennova Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rennova Health Inc. and related stocks with our FREE daily email newsletter.